Summary:
Click image to enlarge
A 52-week, confirmatory, randomised, multicentre, multinational, active-controlled, parallel- groups, double-blind, double-dummy, two-arm trial on the efficacy and safety of semaglutide versus canagliflozin in subjects with type 2 diabetes.
Qualified Participants Must:
• Have Type 2 Diabetes
•
Be taking Metformin 1500 Mg Daily for Diabetes
•
Have a BMI of less than 46
Qualified Participants May Receive:
$45-50 per clinic visit for a total of 10 visits.
Free Labs and Medical procedures
Free Diabetic Supplies